Charles River Laboratories International Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Charles River Laboratories International Inc 公司

Charles River Laboratories International, Inc. 提供基本产品和服务，帮助全球制药和生物技术公司、政府机构和学术机构加速其研究和药物开发工作。该公司的研究模型和服务部门由三项业务组成，提供基础工具，使其客户能够发现新分子：研究模型、研究模型服务和细胞解决方案。其发现和安全评估部门提供受监管和非受监管的 DSA 服务，以支持潜在新药的研究、开发和监管要求的安全测试，包括治疗发现和优化以及体外和体内研究、实验室支持服务以及战略非临床咨询和项目管理，以支持产品开发。其制造解决方案部门包括微生物解决方案和生物制剂解决方案。

Charles River Laboratories International Inc简介



公司代码CRL

公司名称Charles River Laboratories International Inc

上市日期Jun 23, 2000

CEOMr James C. Foster

员工数量18600

证券类型Ordinary Share

年结日Jun 23

公司地址251 Ballardvale St

城市WILMINGTON

上市交易所NYSE Consolidated

国家United States of America

邮编01887

电话17812226000

网址https://www.criver.com/

公司代码CRL

上市日期Jun 23, 2000

CEOMr James C. Foster

Charles River Laboratories International Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

12.48K

-8.77%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

Dr. Nancy C. Andrews, M.D., Ph.D.

Independent Director

3.96K

+31.35%

Ms. Reshema Kemps-Polanco

Independent Director

2.59K

+155.42%

Dr. Craig B. Thompson, M.D.

Independent Director

2.41K

+64.49%

Mr. Abraham N. (Abe) Ceesay

Independent Director

946.00

--

名称

名称/职务

职务

持股

持股变动

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

12.48K

-8.77%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

业务USD

名称

营收

占比

DSA

618.03M

59.88%

RMS

213.27M

20.66%

Manufacturing

200.84M

19.46%

地区USD

名称

营收

占比

United States

549.86M

53.27%

Europe

281.86M

27.31%

Canada

135.59M

13.14%

Asia Pacific (Region)

54.50M

5.28%

Other

10.33M

1.00%

业务

地区

业务USD

名称

营收

占比

DSA

618.03M

59.88%

RMS

213.27M

20.66%

Manufacturing

200.84M

19.46%

股东统计

更新时间: 10月8日周三

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

11.79%

Wellington Management Company, LLP

7.66%

BlackRock Institutional Trust Company, N.A.

5.59%

Allspring Global Investments, LLC

4.43%

State Street Investment Management (US)

3.78%

其他

66.77%

持股股东

占比

The Vanguard Group, Inc.

11.79%

Wellington Management Company, LLP

7.66%

BlackRock Institutional Trust Company, N.A.

5.59%

Allspring Global Investments, LLC

4.43%

State Street Investment Management (US)

3.78%

其他

66.77%

股东类型

持股股东

占比

Investment Advisor

43.53%

Investment Advisor/Hedge Fund

41.31%

Hedge Fund

9.40%

Research Firm

5.95%

Bank and Trust

2.19%

Pension Fund

1.50%

Individual Investor

1.05%

Sovereign Wealth Fund

1.04%

Private Equity

0.20%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

1366

51.65M

104.95%

-10.83M

2025Q2

1399

56.14M

114.06%

-4.38M

2025Q1

1435

55.38M

112.72%

-5.93M

2024Q4

1423

54.85M

107.26%

-4.35M

2024Q3

1392

53.78M

105.14%

-5.12M

2024Q2

1399

54.00M

104.84%

-4.00M

2024Q1

1393

53.76M

104.37%

-4.04M

2023Q4

1424

53.56M

104.42%

-4.24M

2023Q3

1446

53.56M

104.42%

-3.98M

2023Q2

1427

52.88M

103.32%

-3.95M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

5.80M

11.79%

-293.30K

-4.81%

Jun 30, 2025

Wellington Management Company, LLP

3.77M

7.66%

-517.21K

-12.07%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

2.75M

5.59%

-156.85K

-5.39%

Jun 30, 2025

Allspring Global Investments, LLC

2.29M

4.66%

+516.52K

+29.11%

Jun 30, 2025

State Street Investment Management (US)

1.86M

3.78%

-43.84K

-2.30%

Jun 30, 2025

Nomura Securities Co., Ltd.

1.57M

3.19%

+967.65K

+160.84%

Jun 30, 2025

Ariel Investments, LLC

1.42M

2.88%

+314.57K

+28.58%

Jun 30, 2025

Geode Capital Management, L.L.C.

1.23M

2.5%

-31.43K

-2.49%

Jun 30, 2025

Harris Associates L.P.

1.16M

2.36%

+1.16M

--

Jun 30, 2025

Invesco Capital Management LLC

1.09M

2.22%

+110.27K

+11.23%

Jun 30, 2025

持股ETF



更新时间: 10月6日周一

机构名称

占比

First Trust NASDAQ Pharmaceuticals ETF

2.13%

Invesco S&P 500 Equal Weight Health Care ETF

1.78%

VanEck Biotech ETF

1.62%

Schwab Ariel Opportunities ETF

1.61%

ROBO Global Healthcare Technology & Innovation ETF

1.56%

Franklin Genomic Advancements ETF

1.37%

iShares Health Innovation Active ETF

1.29%

Principal Quality ETF

1.01%

WisdomTree US Value Fund

0.98%

Invesco S&P 500 High Beta ETF

0.93%

First Trust NASDAQ Pharmaceuticals ETF

占比2.13%

Invesco S&P 500 Equal Weight Health Care ETF

占比1.78%

VanEck Biotech ETF

占比1.62%

Schwab Ariel Opportunities ETF

占比1.61%

ROBO Global Healthcare Technology & Innovation ETF

占比1.56%

Franklin Genomic Advancements ETF

占比1.37%

iShares Health Innovation Active ETF

占比1.29%

Principal Quality ETF

占比1.01%

WisdomTree US Value Fund

占比0.98%

Invesco S&P 500 High Beta ETF

占比0.93%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据